BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8029157)

  • 1. [Influence of cuprophane membrane surface dialyzers on beta2-microglobulin serum concentration in patients during hemodialysis].
    Szepietowski T; el-Hayek A
    Polim Med; 1993; 23(3-4):43-54. PubMed ID: 8029157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [What is the reason for the increase in beta-2-microglobulin levels in the blood when using cuprophane dialysis membranes?].
    Sulková S; Lapcík O; Votruba T
    Cas Lek Cesk; 1989 Apr; 128(17):520-3. PubMed ID: 2665936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dialysis arthropathy, beta 2-microglobulin and the effect of dialyser membrane.
    Sethi D; Gower PE
    Nephrol Dial Transplant; 1988; 3(6):768-72. PubMed ID: 3147418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT; Williams AW; Johnson WJ
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [C-reactive protein (CRP) as a marker of of hemodialysis biocompatibility].
    Szepietowski T; Krajewska M
    Polim Med; 1997; 27(1-2):47-59. PubMed ID: 9380601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of plasma beta 2 microglobulin concentration: possible relation to membrane biocompatibility.
    Bommer J; Seelig P; Seelig R; Geerlings W; Bommer G; Ritz E
    Nephrol Dial Transplant; 1987; 2(1):22-5. PubMed ID: 3110692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in the beta 2-microglobulin level during hemodialysis].
    Nikitinskaia LP; Stetsiuk EA; Iarmolinskiĭ IS; Barinov AV; Kon'kova TA
    Urol Nefrol (Mosk); 1990; (5):29-31. PubMed ID: 2264202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration.
    Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S
    Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of reprocessing cuprophane and polysulfone dialyzers on beta 2-microglobulin removal from hemodialysis patients.
    Petersen J; Moore RM; Kaczmarek RG; Singh B; Yeh I; Hamburger S; Kankam M
    Am J Kidney Dis; 1991 Feb; 17(2):174-8. PubMed ID: 1992659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between serum beta 2-microglobulin, bone histology, and dialysis membranes in uraemic patients.
    Ferreira A; Ureña P; Ang KS; Simon P; Morieux C; Souberbielle JC; de Vernejoul MC; Drüeke TB
    Nephrol Dial Transplant; 1995; 10(9):1701-7. PubMed ID: 8559492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum beta 2 microglobulin and extracellular fluid volume during haemodialysis.
    Chanard J; Toupance O; Lavaud S; Jaisser F; Gillery P
    Nephrol Dial Transplant; 1989; 4(6):549-54. PubMed ID: 2507977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradialytic body weight changes and dialyzer pore size as main contributing factors to the evolution of beta-2-microglobulin in dialysis.
    Vanholder RC; Ringoir SM
    Blood Purif; 1990; 8(1):32-44. PubMed ID: 2198890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of re-utilization of cuprophan capillary dialysers with different liquids on their biocompatibility and effectiveness of elimination].
    Orłowski A; Szepietowski T
    Polim Med; 1992; 22(1-2):59-72. PubMed ID: 1461837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-2-microglobulin in hemodialysis patients. Effects of different dialyzers and different dialysis procedures.
    Mayer G; Thum J; Woloszczuk W; Graf H
    Am J Nephrol; 1988; 8(4):280-4. PubMed ID: 3055992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of hemodialysis on levels of parathormone in blood of patients with chronic kidney failure].
    Starzyk J; Kowalski D
    Wiad Lek; 1993 Apr; 46(7-8):283-5. PubMed ID: 8249416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dialysis amyloidosis and beta-2-microglobulin].
    Sulková S; Votruba T
    Cas Lek Cesk; 1989 Jan; 128(3):68-73. PubMed ID: 2655913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum beta2-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patients.
    Okuno S; Ishimura E; Kohno K; Fujino-Katoh Y; Maeno Y; Yamakawa T; Inaba M; Nishizawa Y
    Nephrol Dial Transplant; 2009 Feb; 24(2):571-7. PubMed ID: 18799606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.